|
Volumn 150, Issue 5, 2011, Pages 610-613
|
Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency
|
Author keywords
Adenocine; Apoptosis; Bioenergetic insufficiency; Cardiac insufficiency
|
Indexed keywords
ACETYLDIGITOXIN;
ADENOSINE;
ADENOSINE TRIPHOSPHATE;
LEVOSIMENDAN;
MILRINONE;
NICOTINAMIDE ADENINE DINUCLEOTIDE;
POLY(ADENOSINE DIPHOSPHATE RIBOSE);
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
CONTROLLED STUDY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
FEMALE;
HEART FAILURE;
HEART LEFT VENTRICLE MUSCLE;
HEART MUSCLE CELL;
HEART PROTECTION;
HEART RIGHT VENTRICLE;
HEART RIGHT VENTRICLE MUSCLE;
HEART VENTRICLE WALL;
MALE;
NONHUMAN;
ACETYLDIGOXINS;
ADENOSINE;
ADENOSINE TRIPHOSPHATE;
ANIMALS;
APOPTOSIS;
CARDIOTONIC AGENTS;
CONSTRICTION, PATHOLOGIC;
FEMALE;
HEART;
HEART FAILURE;
HEART VENTRICLES;
HYDRAZONES;
MALE;
MILRINONE;
MYOCARDIUM;
MYOCYTES, CARDIAC;
NAD;
POLY(ADP-RIBOSE) POLYMERASES;
PYRIDAZINES;
RABBITS;
REPERFUSION;
VENTRICULAR FUNCTION;
|
EID: 79959222207
PISSN: 00074888
EISSN: 15738221
Source Type: Journal
DOI: 10.1007/s10517-011-1203-5 Document Type: Article |
Times cited : (3)
|
References (10)
|